We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About Nura Bio Stock

Invest in or calculate the value of your shares in Nura Bio or other pre-IPO companies through EquityZen's platform.

Get Started

Nura Bio Stock

Nura Bio is a biotechnology company that develops neuroprotective therapies for neurological disorders.

About Nura Bio Stock

Founded

2018

Headquarters

South San Francisco, CA, US

Industries

Apps, Artificial Intelligence, Software

Nura Bio is a biotechnology company that develops neuroprotective therapies for neurological disorders. Its research focuses on preserving neuronal integrity by targeting pathways involved in axonal degeneration and neuroimmune regulation. The company is advancing small-molecule programs, including inhibitors of the SARM1 protein, which plays a key role in axon degeneration. Nura Bio operates an integrated drug discovery platform that supports activities from target identification and validation through preclinical development. Its scientific efforts aim to address diseases affecting the peripheral, central, and ocular nervous systems.

Nura Bio Press Mentions

Stay in the know about the latest news on Nura Bio

Nura Bio Management

Leadership team at Nura Bio

CEO, President and Board Member

Alpna Seth

Board Of Directors

Sanjay Keswani

Locked Features

Join now and verify your accreditation status to gain access to:

  • Nura Bio Current Valuation
  • Nura Bio Stock Price
  • Nura Bio Management
  • Available deals in Nura Bio and all other companies with relevant Deal Offering documents
  • EquityZen's proprietary data and insights, which may include
    • Nura Bio Cap Table and Funding History by Share Class and Liquidity Preferences
    • Nura Bio Revenue and Financials
    • Nura Bio Highlights
    • Nura Bio Business Model
    • Nura Bio Risk Factors
  • Nura Bio Research Report from SACRA Research
Join Now

Trading Nura Bio Stock

How to invest in Nura Bio stock?

Accredited investors can buy pre-IPO stock in companies like Nura Bio through EquityZen funds. These investments are made available by existing Nura Bio shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.

How to sell Nura Bio stock?

Shareholders can sell their Nura Bio stock through EquityZen's private company marketplace. EquityZen's network includes over 460K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 54K private placements completed across 500+ companies, EquityZen leads the way in delivering "Private Markets for the Public."

More Like Nura Bio